Medicines Forum Africa

medicinesforum.org

Medicines Forum Africa is an open platform for exchange of views between policymakers and stakeholders that aims to enhance public private collaboration in the pharmaceuticals policy-shaping process and making sure that new policies related to access to medicines are goal-oriented, operational and comprehensive. The Forum operates on not-for-profit principles and is incorporated in the United Kingdom as a company limited by guarantee (ie does not have any shares or shareholders), and its surpluses are principally applied toward the promotion of the objects of the Forum.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PHARMACY MARKET

SPOTLITE360 INTRODUCES PHARMACEUTICAL INDUSTRY INITIATIVE FOR SUPPLY CHAIN TRACKING, TRACING, AND SUSTAINABILITY

Spotlite360 | July 07, 2021

news image

SPOTLITE360 TECHNOLOGIES, INC. is happy to announce that it has started an initiative to provide tailored supply chain tracing and tracking solutions for pharmaceutical companies, for which it is now in contract discussions with pharmaceutical firms. This effort coincides with an impending regulatory shift in the USD 1.3 trillion pharmaceutical industry1 that will require companies to comply with the Drug Supply Chain Security Act (“DSCSA”), which requires the deployment of electroni...

Read More

IONIS AND GENUITY SCIENCE ANNOUNCE AGREEMENT DESIGNED TO RAPIDLY TRANSLATE GENOMIC INSIGHTS INTO THERAPEUTICS

Prnewswire | October 01, 2020

news image

Genuity Science, a genomics and data insights organization and Ionis Pharmaceuticals (NASDAQ: IONS), the leader in antisense therapeutics, today announced a broad, multi-year collaboration aimed at accelerating the discovery and development of innovative therapeutics across a range of up to 20 diseases. The collaboration is expected to play an important role in allowing Ionis to continue delivering transformational medicines to patients for many years to come. Genuity Science's approach comb...

Read More

BUSINESS INSIGHTS

CLEARMIND MEDICINE TO PARTNER WITH MICRODOSE FOR PSYCHEDELIC CAPITAL

Clearmind Medicine Inc. | March 25, 2022

news image

Clearmind Medicine Inc. a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, announced that its CEO, Dr. Adi Zuloff-Shani and Mark Haden, VP Business Development, will be presenting in the Psychedelic Capital: March 2022 virtual event. While the presentation is live streamed, lifetime access to recordings will be available to all ticket holders. ...

Read More

BUSINESS INSIGHTS

GOODRX CLOSES ACQUISITION OF VITACARE, A TECH-ENABLED PHARMACY SERVICES PLATFORM

GoodRx | April 18, 2022

news image

GoodRx, a leading consumer-focused digital healthcare platform announced the completion of its previously announced acquisition of vitaCare for $150 million in cash, with an additional $7 million of consideration contingent payment upon vitaCare’s financial performance through 2023. VitaCare is a pharmacy services platform that expands GoodRx’s offering to pharmaceutical manufacturers while helping to improve patient access and adherence to affordable brand drugs. The acquisition wil...

Read More
news image

PHARMACY MARKET

SPOTLITE360 INTRODUCES PHARMACEUTICAL INDUSTRY INITIATIVE FOR SUPPLY CHAIN TRACKING, TRACING, AND SUSTAINABILITY

Spotlite360 | July 07, 2021

SPOTLITE360 TECHNOLOGIES, INC. is happy to announce that it has started an initiative to provide tailored supply chain tracing and tracking solutions for pharmaceutical companies, for which it is now in contract discussions with pharmaceutical firms. This effort coincides with an impending regulatory shift in the USD 1.3 trillion pharmaceutical industry1 that will require companies to comply with the Drug Supply Chain Security Act (“DSCSA”), which requires the deployment of electroni...

Read More
news image

IONIS AND GENUITY SCIENCE ANNOUNCE AGREEMENT DESIGNED TO RAPIDLY TRANSLATE GENOMIC INSIGHTS INTO THERAPEUTICS

Prnewswire | October 01, 2020

Genuity Science, a genomics and data insights organization and Ionis Pharmaceuticals (NASDAQ: IONS), the leader in antisense therapeutics, today announced a broad, multi-year collaboration aimed at accelerating the discovery and development of innovative therapeutics across a range of up to 20 diseases. The collaboration is expected to play an important role in allowing Ionis to continue delivering transformational medicines to patients for many years to come. Genuity Science's approach comb...

Read More
news image

BUSINESS INSIGHTS

CLEARMIND MEDICINE TO PARTNER WITH MICRODOSE FOR PSYCHEDELIC CAPITAL

Clearmind Medicine Inc. | March 25, 2022

Clearmind Medicine Inc. a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, announced that its CEO, Dr. Adi Zuloff-Shani and Mark Haden, VP Business Development, will be presenting in the Psychedelic Capital: March 2022 virtual event. While the presentation is live streamed, lifetime access to recordings will be available to all ticket holders. ...

Read More
news image

BUSINESS INSIGHTS

GOODRX CLOSES ACQUISITION OF VITACARE, A TECH-ENABLED PHARMACY SERVICES PLATFORM

GoodRx | April 18, 2022

GoodRx, a leading consumer-focused digital healthcare platform announced the completion of its previously announced acquisition of vitaCare for $150 million in cash, with an additional $7 million of consideration contingent payment upon vitaCare’s financial performance through 2023. VitaCare is a pharmacy services platform that expands GoodRx’s offering to pharmaceutical manufacturers while helping to improve patient access and adherence to affordable brand drugs. The acquisition wil...

Read More